INANOVATE INC
SIOUX FALLS, SD · CIK 0001366325 · Medtech · Private
Bio-ID biochip platform for detecting multiple biomarkers across a wide dynamic range (7-log) for breast cancer diagnostics
inanovate.com →- Grants
- $4.5M
- 5 awards
- Sector median: 1
- Raised
- $13M
- 10 Form D · Jul 2025
- 15 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 15
- 1 granted · 14 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201520172019202120232025
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $502,408 | |
| Federal grant | Department of Health and Human Services · Phase II · Detecting breast cancer with a simple blood test using an accessible and low-cost novel real-time platform | $299,965 | |
| Federal grant | Department of Health and Human Services · Phase II · Detecting breast cancer with a simple blood test using an accessible and low-cost novel real-time platform | $996,518 | |
| Federal grant | Department of Health and Human Services · Phase II · Detecting breast cancer with a simple blood test using an accessible and low-cost novel real-time platform | $1,985,543 | |
| Federal grant | Department of Health and Human Services · Phase II · Detecting breast cancer with a simple blood test using an accessible and low-cost novel real-time platform | $989,025 | |
| Private capital raised | Form D · SEC | $3,050,609 | |
| Private capital raised | Form D · SEC | $439,244 | |
| Federal grant | National Science Foundation · Phase I · SBIR Phase I: Ultra-High Throughput COVID-19 Serology Test Using a Novel Biomarker Multiplexing System | $255,851 | |
| Private capital raised | Form D · SEC | $455,260 | |
| Private capital raised | Form D · SEC | $1,807,117 | |
| Private capital raised | Form D · SEC | $2,390,000 | |
| Private capital raised | Form D · SEC | $1,500,000 | |
| Private capital raised | Form D · SEC | $1,100,000 | |
| Private capital raised | Form D · SEC | $900,000 | |
| Private capital raised | Form D · SEC | $808,000 |
Federal grant · SBIR/STTRForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1309 | BRIUS Technologies, Inc. | — | $21M |
| 1310 | POTENTIOMETRIC PROBES, LLC | — | — |
| 1311 | LASER BIOANALYTICS LLC | — | — |
| 1312 | INANOVATE INC | — | $13M |
| 1313 | Optain Health, Inc. | — | $31M |
| 1314 | FRESHAIR SENSOR CORPORATION | — | $32M |
| 1315 | NEXTGENJANE INC | — | $19M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- David ArslanianDirector
- Blaine CrissmanDirector
- Michael GoldsteinDirector
- George HolmesDirector
- Kent LehrDirector
- Peter LosDirector
- Randall MarfinDirector
- James OuryDirector · Executive Officer
- Katie PohlsonDirector
- Kamran TahamtanzadeDirector
- David UreDirector · Executive Officer
Patents
- High-throughput Serology Assayapplication
- Reagents and Methods for Cancer Detection, Prognosis, and Therapeutic Monitoringapplication
- Longitudinal Assaygranted
- Capacitive Pumping And Flow Controlapplication
- Method, System, And Device For Analyte Detection And Measurement Using Longitudinal Assayapplication
- Reagents and Methods for Cancer Detection, Prognosis, and Therapeutic Monitoringapplication
- High-Throughput Serology Assayapplication
- Reagents And Methods For Cancer Detection, Prognosis, And Therapeutic Monitoringapplication
- High-throughput Serology Assayapplication
- Cartridge Device For Processing Time-resolved Assaysapplication
- Method, System, And Device For Analyte Detection And Measurement Using Longitudinal Assayapplication
- Analysis Methods Of Time-resolved Assay Dataapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.